10:50 AM EST - Avant Technologies Inc : Announced the completion of its corporate name change to Avaí Bio, Inc. The rebranding, effective today, February 11, 2026, reflects the Company's sharpened focus on advancing transformative treatments for type 1 and insulin-dependent type 2 diabetes, age-related diseases, and healthy longevity through genetically modified cellular platforms and protective encapsulation technologies. Avant Technologies Inc
shares O.AVAI are trading off $0.01 at $0.37.
Full Press Release: https://www.baystreet.ca/quotedata/quote.aspx?ticker=AVAI&qmodStoryID=5755183983662621
